'Our study revealed that, in cancer immunotherapy, there is a strong correlation between clinical outcome and 1-year milestone survival rate, but weak associations with other intermediate endpoints including ORR, disease control rate, and PFS.'
#Immunology #Immunotherapy #immuneoncology

https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(23)00333-4/fulltext